Instil Bio, Inc. (TIL) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
8/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 0 wins, 12 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseTIL / S&P -6.67% / 15.20% |
LoseTIL / S&P TIL unavailable / 15.00% |
LoseTIL / S&P -65.71% / 50.40% |
| 2026-Q10/3 |
LoseTIL / S&P -25.09% / -4.33% |
LoseTIL / S&P TIL unavailable / 11.30% |
LoseTIL / S&P -41.19% / 27.70% |
| 2025-Q40/3 |
LoseTIL / S&P -38.41% / 2.65% |
LoseTIL / S&P TIL unavailable / 9.00% |
LoseTIL / S&P -5.71% / 13.40% |
| 2025-Q30/3 |
LoseTIL / S&P -14.26% / 8.12% |
LoseTIL / S&P TIL unavailable / 4.61% |
LoseTIL / S&P -1.47% / 13.45% |
| 2025-Q21/3 |
WinTIL / S&P 19.99% / 10.94% |
LoseTIL / S&P TIL unavailable / 4.83% |
LoseTIL / S&P -29.74% / 10.63% |
| 2025-Q10/3 |
LoseTIL / S&P -9.06% / -4.27% |
LoseTIL / S&P TIL unavailable / 4.98% |
LoseTIL / S&P -36.90% / 10.57% |
| 2024-Q40/3 |
LoseTIL / S&P -71.64% / 2.41% |
LoseTIL / S&P TIL unavailable / 5.25% |
LoseTIL / S&P -52.54% / 6.15% |
| 2024-Q31/3 |
WinTIL / S&P 554.23% / 5.89% |
LoseTIL / S&P TIL unavailable / 5.89% |
LoseTIL / S&P -79.04% / 6.11% |
| 2024-Q20/3 |
LoseTIL / S&P -4.72% / 4.28% |
LoseTIL / S&P TIL unavailable / 5.38% |
LoseTIL / S&P -59.33% / 5.12% |
| 2024-Q11/3 |
WinTIL / S&P 41.73% / 10.56% |
LoseTIL / S&P TIL unavailable / 5.71% |
LoseTIL / S&P -55.69% / 5.59% |
| 2023-Q40/3 |
LoseTIL / S&P -10.98% / 11.69% |
LoseTIL / S&P TIL unavailable / 6.81% |
LoseTIL / S&P -30.35% / 7.78% |
| 2023-Q31/3 |
LoseTIL / S&P -22.32% / -3.27% |
LoseTIL / S&P TIL unavailable / 7.52% |
WinTIL / S&P 3034.09% / -5.03% |
| 2023-Q21/3 |
LoseTIL / S&P -16.64% / 8.74% |
LoseTIL / S&P TIL unavailable / 9.50% |
WinTIL / S&P 2624.10% / -8.57% |
| 2023-Q11/3 |
LoseTIL / S&P 4.92% / 7.50% |
LoseTIL / S&P TIL unavailable / 10.77% |
WinTIL / S&P 2812.24% / -15.69% |
| 2022-Q41/3 |
LoseTIL / S&P -86.98% / 7.56% |
LoseTIL / S&P TIL unavailable / 11.88% |
WinTIL / S&P 1915.20% / -17.99% |
| 2022-Q31/3 |
WinTIL / S&P 4.76% / -4.88% |
LoseTIL / S&P TIL unavailable / 13.47% |
LoseTIL / S&P -23.48% / -1.41% |
| 2022-Q20/3 |
LoseTIL / S&P -57.02% / -16.10% |
LoseTIL / S&P TIL unavailable / 13.71% |
LoseTIL / S&P -30.83% / 11.04% |
| 2022-Q10/3 |
LoseTIL / S&P -37.17% / -4.60% |
LoseTIL / S&P TIL unavailable / 15.97% |
LoseTIL / S&P -45.15% / 42.23% |
| 2021-Q40/3 |
LoseTIL / S&P -4.28% / 11.03% |
LoseTIL / S&P -100.00% / 15.00% |
LoseTIL / S&P -26.61% / 96.40% |
| 2021-Q30/3 |
LoseTIL / S&P -7.48% / 0.58% |
LoseTIL / S&P TIL unavailable / 10.77% |
LoseTIL / S&P TIL unavailable / 69.42% |
| 2021-Q20/3 |
LoseTIL / S&P -22.97% / 8.55% |
LoseTIL / S&P TIL unavailable / 6.58% |
LoseTIL / S&P TIL unavailable / 51.81% |
| 2021-Q10/3 |
LoseTIL / S&P TIL unavailable / 6.17% |
LoseTIL / S&P TIL unavailable / -1.06% |
LoseTIL / S&P TIL unavailable / 7.39% |
| 2020-Q40/3 |
LoseTIL / S&P TIL unavailable / 12.15% |
LoseTIL / S&P TIL unavailable / -3.72% |
LoseTIL / S&P TIL unavailable / -33.42% |
| 2020-Q30/3 |
LoseTIL / S&P TIL unavailable / 8.93% |
LoseTIL / S&P TIL unavailable / -2.04% |
LoseTIL / S&P TIL unavailable / -27.10% |
| 2020-Q20/3 |
LoseTIL / S&P TIL unavailable / 20.54% |
LoseTIL / S&P TIL unavailable / -0.46% |
LoseTIL / S&P TIL unavailable / -27.11% |
| 2020-Q10/3 |
LoseTIL / S&P TIL unavailable / -19.60% |
LoseTIL / S&P TIL unavailable / 3.47% |
LoseTIL / S&P TIL unavailable / -14.75% |
| 2019-Q40/3 |
LoseTIL / S&P TIL unavailable / 9.07% |
LoseTIL / S&P TIL unavailable / 5.36% |
LoseTIL / S&P TIL unavailable / 2.99% |
| 2019-Q30/3 |
LoseTIL / S&P TIL unavailable / 1.70% |
LoseTIL / S&P TIL unavailable / 5.02% |
LoseTIL / S&P TIL unavailable / 0.21% |
| 2019-Q20/3 |
LoseTIL / S&P TIL unavailable / 4.30% |
LoseTIL / S&P TIL unavailable / 6.64% |
LoseTIL / S&P TIL unavailable / 8.65% |
| 2019-Q10/3 |
LoseTIL / S&P TIL unavailable / 13.65% |
LoseTIL / S&P TIL unavailable / 8.12% |
LoseTIL / S&P TIL unavailable / 14.29% |
| 2018-Q40/3 |
LoseTIL / S&P TIL unavailable / -13.52% |
LoseTIL / S&P TIL unavailable / 9.05% |
LoseTIL / S&P TIL unavailable / 18.23% |
| 2018-Q30/3 |
LoseTIL / S&P TIL unavailable / 7.71% |
LoseTIL / S&P TIL unavailable / 10.21% |
LoseTIL / S&P TIL unavailable / 19.06% |
| 2018-Q20/3 |
LoseTIL / S&P TIL unavailable / 3.43% |
LoseTIL / S&P TIL unavailable / 9.03% |
LoseTIL / S&P TIL unavailable / 14.46% |
| 2018-Q10/3 |
LoseTIL / S&P TIL unavailable / -0.76% |
LoseTIL / S&P TIL unavailable / 7.68% |
LoseTIL / S&P TIL unavailable / 12.46% |
| 2017-Q40/3 |
LoseTIL / S&P TIL unavailable / 6.64% |
LoseTIL / S&P TIL unavailable / 7.03% |
LoseTIL / S&P TIL unavailable / 13.82% |
| 2017-Q30/3 |
LoseTIL / S&P TIL unavailable / 4.48% |
LoseTIL / S&P TIL unavailable / 5.68% |
LoseTIL / S&P TIL unavailable / 17.57% |
| 2017-Q20/3 |
LoseTIL / S&P TIL unavailable / 3.09% |
LoseTIL / S&P TIL unavailable / 4.83% |
LoseTIL / S&P TIL unavailable / 17.74% |
| 2017-Q10/3 |
LoseTIL / S&P TIL unavailable / 6.07% |
LoseTIL / S&P TIL unavailable / 3.67% |
LoseTIL / S&P TIL unavailable / 13.32% |
| 2016-Q40/3 |
LoseTIL / S&P TIL unavailable / 3.82% |
LoseTIL / S&P TIL unavailable / 2.09% |
LoseTIL / S&P TIL unavailable / 7.05% |
| 2016-Q30/3 |
LoseTIL / S&P TIL unavailable / 3.85% |
LoseTIL / S&P TIL unavailable / 0.20% |
LoseTIL / S&P TIL unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | TIL total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -70.89% | 20.78% |
| Annualized return | -70.89% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | TIL total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -97.94% | 83.14% |
| Annualized return | -54.00% | 12.86% |
10Y · 2021-03-19 to 2026-08-27
| Metric | TIL total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -98.51% | 319.30% |
| Annualized return | -34.35% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |